BP
AGN

Ballentine Partners’s Allergan plc AGN Stock Holding History

Ballentine Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,393
Closed -$247K – 395
2020
Q1 		$247K Buy
1,393
+241
+21% +$45.4K 0.01% 282
2019
Q4 		$220K Buy
+1,152
New +$208K 0.01% 356
2018
Q2 		– Sell
-1,624
Closed -$273K – 387
2018
Q1 		$273K Sell
1,624
-673
-29% -$113K 0.02% 267
2017
Q4 		$376K Sell
2,297
-367
-14% -$65.9K 0.02% 232
2017
Q3 		$546K Buy
2,664
+295
+12% +$68.6K 0.03% 182
2017
Q2 		$598K Sell
2,369
-506
-18% -$119K 0.04% 174
2017
Q1 		$688K Buy
2,875
+142
+5% +$33.1K 0.05% 97
2016
Q4 		$579K Sell
2,733
-1,969
-42% -$408K 0.04% 94
2016
Q3 		$1.08M Buy
4,702
+3,624
+336% +$886K 0.09% 54
2016
Q2 		$249K Sell
1,078
-379
-26% -$87.4K 0.02% 170
2016
Q1 		$392K Buy
1,457
+133
+10% +$38.1K 0.03% 133
2015
Q4 		$414K Buy
1,324
+112
+9% +$33.3K 0.04% 109
2015
Q3 		$329K Buy
1,212
+24
+2% +$7.37K 0.03% 119
2015
Q2 		$360K Sell
1,188
-14
-1% -$4.18K 0.04% 119
2015
Q1 		$358K Buy
1,202
+65
+6% +$18.5K 0.04% 116
2014
Q4 		$293K Hold
1,137
– – 0.03% 125
2014
Q3 		$274K Buy
+1,137
New +$254K 0.03% 118

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Ballentine Partners's AGN Position: Q2 2020 in Review

Ballentine Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,393 shares — an estimated $247K sold.

Ballentine Partners first reported a position in AGN in Q3 2014 and held it in 17 quarters. The position peaked at $1.08M in Q3 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ballentine Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ballentine Partners sold 1,393 Allergan plc shares in Q2 2020, an estimated $247K.
  • Ballentine Partners first reported a position in Allergan plc in Q3 2014 and held it in 17 quarters.
  • Ballentine Partners's Allergan plc position peaked at $1.08M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ballentine Partners's 13F filing for Q2 2020, filed 31 Jul 2020.